Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Boehringer collaborates with biotech firm to detect global disease outbreaks
Lifebit's REAL platform will monitor and interpret scientific publications and other open sources to identify infectious disease outbreaks.

Project will combine real-world evidence with AI to track transboundary infections.

Boehringer Ingelheim has announced a multi-year partnership with biotech firm Lifebit to detect and report global disease outbreaks. 

Through the partnership, scientists will work collaboratively to combine real-world evidence and the latest AI algorithms to identify diseases, particularly those that cross borders, and respond accordingly. 

Lifebit's REAL platform analyses data harvested from millions of tweets, news articles and scientific publications to notify users of relevant disease outbreaks, such as COVID-19. 

As well as speeding up the detection of the latest outbreaks, researchers hope the insights will enable Boehringer’s research and development efforts to be prioritised accordingly.

“External innovation is becoming an increasingly important aspect of our R&D playbook. Therefore, we are strategically partnering with Lifebit to leverage AI to monitor and interpret scientific and other sources in real-time, enabling us to track data related to animal diseases,” commented Dr Eric Haaksma, head of animal health global innovation at Boehringer Ingelheim.

“This, in turn, will accelerate the detection process as the vast amounts of scientific relevant information being produced at many levels cannot be feasibly collected and analysed manually.”

Lifebit CEO Dr Maria Chatzou-Dunford added: “At Lifebit, we thrive at connecting both, locked-up sensitive biomedical data from around the world and AI-driven automated RWE data insights – so that companies at the cutting edge of science, like Boehringer Ingelheim, can make faster and smarter decisions – delivering insights that change lives.”

Become a member or log in to add this story to your CPD history

Vets asked to opt-in to Scottish SPCA fostering programme

News Story 1
 The Scottish SPCA is encouraging veterinary practices to opt into its new fostering programme, by agreeing to register foster animals when approached by one of the foster carers.

The programme goes live in August 2021, and will help to rehabilitate animals under the Scottish SPCA's care until they are able to be properly re-homed. The programme will help the animals to receive care and attention in a stable and happy home environment, as some animals do not cope with a rescue and re-homing centre environment as well as others.

Specific information for veterinary practices on the new programme can be found at www.scottishspca.org/veterinarysurgeons 

Click here for more...
News Shorts
Webinar provides insight into old age pets

A new webinar providing insights into the BSAVA PetSavers Old Age Pets citizen science project is now available free of charge to its members via the BSAVA Library

The webinar presents an exclusive insight into the research process and progression of the study, which aims to help veterinary professionals and owners provide the best care for their senior dogs.

It also discusses the study's research methods, the researchers' personal interests in this area of study, and how they envisage the findings being used to create a guidance tool to improve discussions between vets and owners about their ageing dogs.